Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

morgan-stanley-maintains-overweight-on-renaissancere-holdings-ltd-(rnr)-feb-$310

Morgan Stanley Maintains Overweight on RenaissanceRe Holdings Ltd (RNR) Feb $310

Feb 9, 2026

Morgan Stanley on February 6, 2026 maintained an Overweight rating on RenaissanceRe Holdings Ltd. (RNR) and raised the…

Read more
morgan-stanley-maintains-overweight-on-rbc-bearings-incorporated-(rbc)-feb-2026

Morgan Stanley Maintains Overweight on RBC Bearings Incorporated (RBC) Feb 2026

Feb 9, 2026

Morgan Stanley on Feb 06, 2026 at 11:00 AM maintained an Overweight rating on RBC Bearings Incorporated (RBC)…

Read more
citigroup-maintained-buy-on-roblox-(rblx)-feb-06,-2026

Citigroup Maintained Buy on Roblox (RBLX) Feb 06, 2026

Feb 9, 2026

RBLX analyst rating: Citigroup maintained Buy on Roblox Corporation on February 06, 2026, while lowering its price target…

Read more
hc.-wainwright-maintains-buy-on-strategy-inc-(mstr)-feb-2026

H.C. Wainwright Maintains Buy on Strategy Inc (MSTR) Feb 2026

Feb 9, 2026

H.C. Wainwright maintained a Buy rating on Strategy Inc (MSTR) on Feb 06, 2026, and raised the price…

Read more
citigroup-maintains-buy-on-assa-abloy-ab-(publ)-asazy,-feb-2026

Citigroup Maintains Buy on ASSA ABLOY AB (publ) ASAZY, Feb 2026

Feb 9, 2026

Citigroup maintained a Buy on ASSA ABLOY AB (publ) (ASAZY) on Feb 06, 2026 at 02:45 PM, and…

Read more
mdln-medline-inc.-feb-2026-tigress-financial-initiates-coverage-with-buy

MDLN Medline Inc. Feb 2026 Tigress Financial Initiates Coverage with Buy

Feb 8, 2026

Tigress Financial initiated coverage of Medline Inc. (MDLN) with a Buy on February 5, 2026. The MDLN analyst…

Read more
2026-research-agenda:-key-topics-and-coverage-areas

2026 Research Agenda: Key Topics and Coverage Areas

Feb 7, 2026

Enterprise Applications are the lifeblood and framework for accomplishing work in the modern organization. We examine 12 categories…

Read more
deutsche-bank-maintains-hold-on-aurubis-ag-(aiagy)-feb-06-2026

Deutsche Bank Maintains Hold on Aurubis AG (AIAGY) Feb 06 2026

Feb 7, 2026

Deutsche Bank maintained a Hold on Aurubis AG (AIAGY) on Feb 06, 2026, while raising its price target…

Read more
deutsche-bank-maintains-buy-on-sloiy-soitec-sa.,-raises-pt-to-eur-44-feb-2026

Deutsche Bank Maintains Buy on SLOIY Soitec S.A., Raises PT to EUR 44 Feb 2026

Feb 7, 2026

Deutsche Bank kept a Buy on Soitec S.A. (SLOIY) and raised the price target to EUR 44. The…

Read more
morgan-stanley-maintains-overweight-on-dsdvy-(dsv-a/s);-citi-keeps-neutral-feb-2026

Morgan Stanley Maintains Overweight on DSDVY (DSV A/S); Citi Keeps Neutral Feb 2026

Feb 7, 2026

On February 06, 2026 Morgan Stanley maintained an Overweight rating on DSV A/S (DSDVY) and raised its price…

Read more
a-look-at-cava-group-(cava)-valuation-as-fresh-analyst-buy-ratings-highlight-growth-potential

A Look At Cava Group (CAVA) Valuation As Fresh Analyst Buy Ratings Highlight Growth Potential

Feb 6, 2026

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…

Read more
oppenheimer-initiates-whitehawk-therapeutics-(whwk)-with-outperform-feb-2026

Oppenheimer initiates Whitehawk Therapeutics (WHWK) with Outperform Feb 2026

Feb 6, 2026

Oppenheimer on February 05, 2026 initiated coverage of Whitehawk Therapeutics Inc (WHWK) with an Outperform rating. This WHWK…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 44
  6. 45
  7. 46
  8. 47
  9. 48
  10. 49
  11. 50
  12. ...
  13. 378
  14. »

Posts pagination

Newer posts Page 1 … Page 47 … Page 378 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.